Ma J, Fu Y, Chen X, Lin Y, Zeng L, Mei F
Medicina (Kaunas). 2024; 60(11).
PMID: 39596965
PMC: 11596673.
DOI: 10.3390/medicina60111780.
Kakegawa T, Sugimoto K, Kamiyama N, Hashimoto H, Takahashi H, Wada T
Ultrasonography. 2024; 43(6):457-468.
PMID: 39370861
PMC: 11532521.
DOI: 10.14366/usg.24100.
Junhong R, Wen H
Aging Med (Milton). 2024; 7(4):429-437.
PMID: 39234205
PMC: 11369325.
DOI: 10.1002/agm2.12345.
Han S, Sung P, Park S, Kim J, Hong H, Yoon J
Gut Liver. 2024; 18(5):789-802.
PMID: 39223081
PMC: 11391139.
DOI: 10.5009/gnl240350.
Han S, Sung P, Park S, Kim J, Hong H, Yoon J
J Liver Cancer. 2024; 24(2):131-144.
PMID: 39210668
PMC: 11449576.
DOI: 10.17998/jlc.2024.08.04.
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association.
Han S, Sung P, Park S, Kim J, Hong H, Yoon J
Korean J Radiol. 2024; 25(9):773-787.
PMID: 39197823
PMC: 11361797.
DOI: 10.3348/kjr.2024.0550.
The American College of Radiology contrast-enhanced ultrasound Liver Imaging Reporting and Data System and its modified version in diagnosing hepatocellular carcinoma via Sonazoid: a meta-analysis.
Cao J, Wang H, Ruan X, Yang J, Ren Y, Ling W
Quant Imaging Med Surg. 2024; 14(7):4555-4566.
PMID: 39022290
PMC: 11250333.
DOI: 10.21037/qims-23-1459.
Compared with SonoVue LR-5, Sonazoid modified LR-5 has better diagnostic sensitivity for hepatocellular carcinoma: a systematic review and meta-analysis.
Cao J, Wang H, Ling W
Quant Imaging Med Surg. 2024; 14(4):2978-2992.
PMID: 38617150
PMC: 11007517.
DOI: 10.21037/qims-23-1616.
Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
Lee Y, Yoon J, Han S, Joo I, Lee J
Cancer Imaging. 2024; 24(1):4.
PMID: 38172949
PMC: 10762814.
DOI: 10.1186/s40644-023-00650-y.
Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound.
Kamiyama N, Sugimoto K, Nakahara R, Kakegawa T, Itoi T
J Med Ultrason (2001). 2023; 51(1):83-93.
PMID: 38051461
DOI: 10.1007/s10396-023-01390-z.
Quantitative Pharmacokinetics Reveal Impact of Lipid Composition on Microbubble and Nanoprogeny Shell Fate.
Rajora M, Dhaliwal A, Zheng M, Choi V, Overchuk M, Lou J
Adv Sci (Weinh). 2023; 11(4):e2304453.
PMID: 38032129
PMC: 10811482.
DOI: 10.1002/advs.202304453.
Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J, Lu Q, Fei X, Dong Y, D Onofrio M, Sidhu P
Eur Radiol. 2023; 34(6):3795-3812.
PMID: 37989916
DOI: 10.1007/s00330-023-10371-2.
Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities.
Shimizu R, Ida Y, Kitano M
Diagnostics (Basel). 2023; 13(19).
PMID: 37835800
PMC: 10572637.
DOI: 10.3390/diagnostics13193058.
Identification of sentinel lymph nodes in esophageal cancer patients using contrast-enhanced EUS with peritumoral injections.
Liu J, Machado P, Eisenbrey J, Gummadi S, Forsberg F, Wessner C
Endosc Ultrasound. 2023; 12(4):362-368.
PMID: 37795347
PMC: 10547247.
DOI: 10.1097/eus.0000000000000001.
Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.
Jeong W
J Liver Cancer. 2023; 23(2):272-283.
PMID: 37723641
PMC: 10565540.
DOI: 10.17998/jlc.2023.08.25.
Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
Wang S, Yao J, Li K, Yang H, Lu S, He G
Abdom Radiol (NY). 2023; 48(10):3101-3113.
PMID: 37436451
DOI: 10.1007/s00261-023-03993-z.
Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline.
Kang H, Lee J, Kim S
Ultrasonography. 2023; 42(4):479-489.
PMID: 37423603
PMC: 10555687.
DOI: 10.14366/usg.23051.
Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma.
Sugimoto K, Kamiyama N, Kakegawa T, Takahashi H, Wada T, Abe M
Ultrasonography. 2023; 42(3):388-399.
PMID: 37340572
PMC: 10331059.
DOI: 10.14366/usg.23065.
Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study.
Yao J, Li K, Yang H, Lu S, Ding H, Luo Y
Eur Radiol. 2023; 33(10):7066-7076.
PMID: 37115213
DOI: 10.1007/s00330-023-09656-3.
Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae J, Lee J, Suh K, Hong S, Yoon J, Kim Y
Abdom Radiol (NY). 2023; 48(7):2321-2330.
PMID: 37097451
DOI: 10.1007/s00261-023-03901-5.